- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00230906
Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane
December 19, 2007 updated by: University Hospital, Ghent
Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane
Study Type
Interventional
Enrollment
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ghent, Belgium, 9000
- University Hospital Ghent
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Chronic haemodialysis patient
- Serum albumin > 3.6 g/dl
Exclusion Criteria:
- < 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Concentration of uremic components after 3 weeks of haemodialysis
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Raymond Van Holder, MD, PhD, University Hospital, Ghent
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2001
Study Completion (Actual)
April 1, 2002
Study Registration Dates
First Submitted
September 29, 2005
First Submitted That Met QC Criteria
September 29, 2005
First Posted (Estimate)
October 3, 2005
Study Record Updates
Last Update Posted (Estimate)
December 28, 2007
Last Update Submitted That Met QC Criteria
December 19, 2007
Last Verified
December 1, 2007
More Information
Terms related to this study
Other Study ID Numbers
- 2001/182
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Haemodialysis
-
University Hospital, BrestCompleted
-
University Hospital, BrestUnknown
-
The Leeds Teaching Hospitals NHS TrustUnknownHaemodialysis ComplicationUnited Kingdom
-
Université de Reims Champagne-ArdenneNot yet recruitingHaemodialysis PatientsFrance
-
Bayburt UniversityActive, not recruitingHaemodialysis PatientsTurkey
-
Great Ormond Street Hospital for Children NHS Foundation...UnknownChildren | Haemodialysis | HaemodiafiltrationUnited Kingdom
-
University Medical Center GroningenMartini Hospital GroningenCompleted
-
Bangkok Metropolitan Administration Medical College...CompletedHaemodialysis | Heparin | Hemodiafiltration | Citrate ReactionThailand
-
Ospedale Regionale di LocarnoFondazione Ettore Balli LocarnoCompleted
Clinical Trials on Haemodialysis with either low or high flux membranes
-
Shahid Beheshti University of Medical SciencesCompletedCataractIran, Islamic Republic of
-
University of CopenhagenThe Fisheries and Aquaculture Industry Research Fund; National Institute of...Completed
-
University of BolognaEuropean CommissionUnknown
-
Weill Medical College of Cornell UniversityWithdrawn
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted